Global Plasma Derived Medicine Market Research Report 2024(Status and Outlook)
Report Overview:
Plasma Derived Medicine is any therapeutic substance prepared from human blood.
The Global Plasma Derived Medicine Market Size was estimated at USD 2456.59 million in 2023 and is projected to reach USD 3855.18 million by 2029, exhibiting a CAGR of 7.80% during the forecast period.
This report provides a deep insight into the global Plasma Derived Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Plasma Derived Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Plasma Derived Medicine market in any manner.
Global Plasma Derived Medicine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
Shanghai RAAS
China Biologic Products
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Boya Bio-Pharmaceutical
Paisi Feike Biology Pharmacy Co., Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd
Market Segmentation (by Type)
Albumin
Immune Globulin
Coagulation Factor
Others
Market Segmentation (by Application)
Bleeding Wound
Immunodeficiency
HBV
Tetanus
Rabies
Hemophilia
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma Derived Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Plasma Derived Medicine is any therapeutic substance prepared from human blood.
The Global Plasma Derived Medicine Market Size was estimated at USD 2456.59 million in 2023 and is projected to reach USD 3855.18 million by 2029, exhibiting a CAGR of 7.80% during the forecast period.
This report provides a deep insight into the global Plasma Derived Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Plasma Derived Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Plasma Derived Medicine market in any manner.
Global Plasma Derived Medicine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
Shanghai RAAS
China Biologic Products
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Boya Bio-Pharmaceutical
Paisi Feike Biology Pharmacy Co., Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd
Market Segmentation (by Type)
Albumin
Immune Globulin
Coagulation Factor
Others
Market Segmentation (by Application)
Bleeding Wound
Immunodeficiency
HBV
Tetanus
Rabies
Hemophilia
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Plasma Derived Medicine Market
- Overview of the regional outlook of the Plasma Derived Medicine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma Derived Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Plasma Derived Medicine
1.2 Key Market Segments
1.2.1 Plasma Derived Medicine Segment by Type
1.2.2 Plasma Derived Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PLASMA DERIVED MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Plasma Derived Medicine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Plasma Derived Medicine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PLASMA DERIVED MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Plasma Derived Medicine Sales by Manufacturers (2019-2024)
3.2 Global Plasma Derived Medicine Revenue Market Share by Manufacturers (2019-2024)
3.3 Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Plasma Derived Medicine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Plasma Derived Medicine Sales Sites, Area Served, Product Type
3.6 Plasma Derived Medicine Market Competitive Situation and Trends
3.6.1 Plasma Derived Medicine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Plasma Derived Medicine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PLASMA DERIVED MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Plasma Derived Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PLASMA DERIVED MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PLASMA DERIVED MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma Derived Medicine Sales Market Share by Type (2019-2024)
6.3 Global Plasma Derived Medicine Market Size Market Share by Type (2019-2024)
6.4 Global Plasma Derived Medicine Price by Type (2019-2024)
7 PLASMA DERIVED MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma Derived Medicine Market Sales by Application (2019-2024)
7.3 Global Plasma Derived Medicine Market Size (M USD) by Application (2019-2024)
7.4 Global Plasma Derived Medicine Sales Growth Rate by Application (2019-2024)
8 PLASMA DERIVED MEDICINE MARKET SEGMENTATION BY REGION
8.1 Global Plasma Derived Medicine Sales by Region
8.1.1 Global Plasma Derived Medicine Sales by Region
8.1.2 Global Plasma Derived Medicine Sales Market Share by Region
8.2 North America
8.2.1 North America Plasma Derived Medicine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Plasma Derived Medicine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Plasma Derived Medicine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Plasma Derived Medicine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Plasma Derived Medicine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Takeda
9.1.1 Takeda Plasma Derived Medicine Basic Information
9.1.2 Takeda Plasma Derived Medicine Product Overview
9.1.3 Takeda Plasma Derived Medicine Product Market Performance
9.1.4 Takeda Business Overview
9.1.5 Takeda Plasma Derived Medicine SWOT Analysis
9.1.6 Takeda Recent Developments
9.2 CSL
9.2.1 CSL Plasma Derived Medicine Basic Information
9.2.2 CSL Plasma Derived Medicine Product Overview
9.2.3 CSL Plasma Derived Medicine Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Plasma Derived Medicine SWOT Analysis
9.2.6 CSL Recent Developments
9.3 Grifols
9.3.1 Grifols Plasma Derived Medicine Basic Information
9.3.2 Grifols Plasma Derived Medicine Product Overview
9.3.3 Grifols Plasma Derived Medicine Product Market Performance
9.3.4 Grifols Plasma Derived Medicine SWOT Analysis
9.3.5 Grifols Business Overview
9.3.6 Grifols Recent Developments
9.4 Octapharma
9.4.1 Octapharma Plasma Derived Medicine Basic Information
9.4.2 Octapharma Plasma Derived Medicine Product Overview
9.4.3 Octapharma Plasma Derived Medicine Product Market Performance
9.4.4 Octapharma Business Overview
9.4.5 Octapharma Recent Developments
9.5 Kedrion
9.5.1 Kedrion Plasma Derived Medicine Basic Information
9.5.2 Kedrion Plasma Derived Medicine Product Overview
9.5.3 Kedrion Plasma Derived Medicine Product Market Performance
9.5.4 Kedrion Business Overview
9.5.5 Kedrion Recent Developments
9.6 LFB Group
9.6.1 LFB Group Plasma Derived Medicine Basic Information
9.6.2 LFB Group Plasma Derived Medicine Product Overview
9.6.3 LFB Group Plasma Derived Medicine Product Market Performance
9.6.4 LFB Group Business Overview
9.6.5 LFB Group Recent Developments
9.7 Biotest
9.7.1 Biotest Plasma Derived Medicine Basic Information
9.7.2 Biotest Plasma Derived Medicine Product Overview
9.7.3 Biotest Plasma Derived Medicine Product Market Performance
9.7.4 Biotest Business Overview
9.7.5 Biotest Recent Developments
9.8 BPL
9.8.1 BPL Plasma Derived Medicine Basic Information
9.8.2 BPL Plasma Derived Medicine Product Overview
9.8.3 BPL Plasma Derived Medicine Product Market Performance
9.8.4 BPL Business Overview
9.8.5 BPL Recent Developments
9.9 Shanghai RAAS
9.9.1 Shanghai RAAS Plasma Derived Medicine Basic Information
9.9.2 Shanghai RAAS Plasma Derived Medicine Product Overview
9.9.3 Shanghai RAAS Plasma Derived Medicine Product Market Performance
9.9.4 Shanghai RAAS Business Overview
9.9.5 Shanghai RAAS Recent Developments
9.10 China Biologic Products
9.10.1 China Biologic Products Plasma Derived Medicine Basic Information
9.10.2 China Biologic Products Plasma Derived Medicine Product Overview
9.10.3 China Biologic Products Plasma Derived Medicine Product Market Performance
9.10.4 China Biologic Products Business Overview
9.10.5 China Biologic Products Recent Developments
9.11 Hualan Biological Engineering Inc.
9.11.1 Hualan Biological Engineering Inc. Plasma Derived Medicine Basic Information
9.11.2 Hualan Biological Engineering Inc. Plasma Derived Medicine Product Overview
9.11.3 Hualan Biological Engineering Inc. Plasma Derived Medicine Product Market Performance
9.11.4 Hualan Biological Engineering Inc. Business Overview
9.11.5 Hualan Biological Engineering Inc. Recent Developments
9.12 Beijing Tiantan Biological Products Corp
9.12.1 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Basic Information
9.12.2 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Overview
9.12.3 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Market Performance
9.12.4 Beijing Tiantan Biological Products Corp Business Overview
9.12.5 Beijing Tiantan Biological Products Corp Recent Developments
9.13 Pacific Shuanglin
9.13.1 Pacific Shuanglin Plasma Derived Medicine Basic Information
9.13.2 Pacific Shuanglin Plasma Derived Medicine Product Overview
9.13.3 Pacific Shuanglin Plasma Derived Medicine Product Market Performance
9.13.4 Pacific Shuanglin Business Overview
9.13.5 Pacific Shuanglin Recent Developments
9.14 Boya Bio-Pharmaceutical
9.14.1 Boya Bio-Pharmaceutical Plasma Derived Medicine Basic Information
9.14.2 Boya Bio-Pharmaceutical Plasma Derived Medicine Product Overview
9.14.3 Boya Bio-Pharmaceutical Plasma Derived Medicine Product Market Performance
9.14.4 Boya Bio-Pharmaceutical Business Overview
9.14.5 Boya Bio-Pharmaceutical Recent Developments
9.15 Paisi Feike Biology Pharmacy Co., Ltd.
9.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Basic Information
9.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Overview
9.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Market Performance
9.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
9.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
9.16 Xinjiang Deyuan Bioengineering
9.16.1 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Basic Information
9.16.2 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Overview
9.16.3 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Market Performance
9.16.4 Xinjiang Deyuan Bioengineering Business Overview
9.16.5 Xinjiang Deyuan Bioengineering Recent Developments
9.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
9.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Basic Information
9.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Overview
9.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Market Performance
9.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
9.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
9.18 Shenzhen Weiguang
9.18.1 Shenzhen Weiguang Plasma Derived Medicine Basic Information
9.18.2 Shenzhen Weiguang Plasma Derived Medicine Product Overview
9.18.3 Shenzhen Weiguang Plasma Derived Medicine Product Market Performance
9.18.4 Shenzhen Weiguang Business Overview
9.18.5 Shenzhen Weiguang Recent Developments
9.19 Shanxi Kangbao
9.19.1 Shanxi Kangbao Plasma Derived Medicine Basic Information
9.19.2 Shanxi Kangbao Plasma Derived Medicine Product Overview
9.19.3 Shanxi Kangbao Plasma Derived Medicine Product Market Performance
9.19.4 Shanxi Kangbao Business Overview
9.19.5 Shanxi Kangbao Recent Developments
9.20 Nanyue Biopharming Corporation Ltd
9.20.1 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Basic Information
9.20.2 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Overview
9.20.3 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Market Performance
9.20.4 Nanyue Biopharming Corporation Ltd Business Overview
9.20.5 Nanyue Biopharming Corporation Ltd Recent Developments
10 PLASMA DERIVED MEDICINE MARKET FORECAST BY REGION
10.1 Global Plasma Derived Medicine Market Size Forecast
10.2 Global Plasma Derived Medicine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Plasma Derived Medicine Market Size Forecast by Country
10.2.3 Asia Pacific Plasma Derived Medicine Market Size Forecast by Region
10.2.4 South America Plasma Derived Medicine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Plasma Derived Medicine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Plasma Derived Medicine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Plasma Derived Medicine by Type (2025-2030)
11.1.2 Global Plasma Derived Medicine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Plasma Derived Medicine by Type (2025-2030)
11.2 Global Plasma Derived Medicine Market Forecast by Application (2025-2030)
11.2.1 Global Plasma Derived Medicine Sales (Kilotons) Forecast by Application
11.2.2 Global Plasma Derived Medicine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Plasma Derived Medicine
1.2 Key Market Segments
1.2.1 Plasma Derived Medicine Segment by Type
1.2.2 Plasma Derived Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PLASMA DERIVED MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Plasma Derived Medicine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Plasma Derived Medicine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PLASMA DERIVED MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Plasma Derived Medicine Sales by Manufacturers (2019-2024)
3.2 Global Plasma Derived Medicine Revenue Market Share by Manufacturers (2019-2024)
3.3 Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Plasma Derived Medicine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Plasma Derived Medicine Sales Sites, Area Served, Product Type
3.6 Plasma Derived Medicine Market Competitive Situation and Trends
3.6.1 Plasma Derived Medicine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Plasma Derived Medicine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PLASMA DERIVED MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Plasma Derived Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PLASMA DERIVED MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PLASMA DERIVED MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma Derived Medicine Sales Market Share by Type (2019-2024)
6.3 Global Plasma Derived Medicine Market Size Market Share by Type (2019-2024)
6.4 Global Plasma Derived Medicine Price by Type (2019-2024)
7 PLASMA DERIVED MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma Derived Medicine Market Sales by Application (2019-2024)
7.3 Global Plasma Derived Medicine Market Size (M USD) by Application (2019-2024)
7.4 Global Plasma Derived Medicine Sales Growth Rate by Application (2019-2024)
8 PLASMA DERIVED MEDICINE MARKET SEGMENTATION BY REGION
8.1 Global Plasma Derived Medicine Sales by Region
8.1.1 Global Plasma Derived Medicine Sales by Region
8.1.2 Global Plasma Derived Medicine Sales Market Share by Region
8.2 North America
8.2.1 North America Plasma Derived Medicine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Plasma Derived Medicine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Plasma Derived Medicine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Plasma Derived Medicine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Plasma Derived Medicine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Takeda
9.1.1 Takeda Plasma Derived Medicine Basic Information
9.1.2 Takeda Plasma Derived Medicine Product Overview
9.1.3 Takeda Plasma Derived Medicine Product Market Performance
9.1.4 Takeda Business Overview
9.1.5 Takeda Plasma Derived Medicine SWOT Analysis
9.1.6 Takeda Recent Developments
9.2 CSL
9.2.1 CSL Plasma Derived Medicine Basic Information
9.2.2 CSL Plasma Derived Medicine Product Overview
9.2.3 CSL Plasma Derived Medicine Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Plasma Derived Medicine SWOT Analysis
9.2.6 CSL Recent Developments
9.3 Grifols
9.3.1 Grifols Plasma Derived Medicine Basic Information
9.3.2 Grifols Plasma Derived Medicine Product Overview
9.3.3 Grifols Plasma Derived Medicine Product Market Performance
9.3.4 Grifols Plasma Derived Medicine SWOT Analysis
9.3.5 Grifols Business Overview
9.3.6 Grifols Recent Developments
9.4 Octapharma
9.4.1 Octapharma Plasma Derived Medicine Basic Information
9.4.2 Octapharma Plasma Derived Medicine Product Overview
9.4.3 Octapharma Plasma Derived Medicine Product Market Performance
9.4.4 Octapharma Business Overview
9.4.5 Octapharma Recent Developments
9.5 Kedrion
9.5.1 Kedrion Plasma Derived Medicine Basic Information
9.5.2 Kedrion Plasma Derived Medicine Product Overview
9.5.3 Kedrion Plasma Derived Medicine Product Market Performance
9.5.4 Kedrion Business Overview
9.5.5 Kedrion Recent Developments
9.6 LFB Group
9.6.1 LFB Group Plasma Derived Medicine Basic Information
9.6.2 LFB Group Plasma Derived Medicine Product Overview
9.6.3 LFB Group Plasma Derived Medicine Product Market Performance
9.6.4 LFB Group Business Overview
9.6.5 LFB Group Recent Developments
9.7 Biotest
9.7.1 Biotest Plasma Derived Medicine Basic Information
9.7.2 Biotest Plasma Derived Medicine Product Overview
9.7.3 Biotest Plasma Derived Medicine Product Market Performance
9.7.4 Biotest Business Overview
9.7.5 Biotest Recent Developments
9.8 BPL
9.8.1 BPL Plasma Derived Medicine Basic Information
9.8.2 BPL Plasma Derived Medicine Product Overview
9.8.3 BPL Plasma Derived Medicine Product Market Performance
9.8.4 BPL Business Overview
9.8.5 BPL Recent Developments
9.9 Shanghai RAAS
9.9.1 Shanghai RAAS Plasma Derived Medicine Basic Information
9.9.2 Shanghai RAAS Plasma Derived Medicine Product Overview
9.9.3 Shanghai RAAS Plasma Derived Medicine Product Market Performance
9.9.4 Shanghai RAAS Business Overview
9.9.5 Shanghai RAAS Recent Developments
9.10 China Biologic Products
9.10.1 China Biologic Products Plasma Derived Medicine Basic Information
9.10.2 China Biologic Products Plasma Derived Medicine Product Overview
9.10.3 China Biologic Products Plasma Derived Medicine Product Market Performance
9.10.4 China Biologic Products Business Overview
9.10.5 China Biologic Products Recent Developments
9.11 Hualan Biological Engineering Inc.
9.11.1 Hualan Biological Engineering Inc. Plasma Derived Medicine Basic Information
9.11.2 Hualan Biological Engineering Inc. Plasma Derived Medicine Product Overview
9.11.3 Hualan Biological Engineering Inc. Plasma Derived Medicine Product Market Performance
9.11.4 Hualan Biological Engineering Inc. Business Overview
9.11.5 Hualan Biological Engineering Inc. Recent Developments
9.12 Beijing Tiantan Biological Products Corp
9.12.1 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Basic Information
9.12.2 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Overview
9.12.3 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Market Performance
9.12.4 Beijing Tiantan Biological Products Corp Business Overview
9.12.5 Beijing Tiantan Biological Products Corp Recent Developments
9.13 Pacific Shuanglin
9.13.1 Pacific Shuanglin Plasma Derived Medicine Basic Information
9.13.2 Pacific Shuanglin Plasma Derived Medicine Product Overview
9.13.3 Pacific Shuanglin Plasma Derived Medicine Product Market Performance
9.13.4 Pacific Shuanglin Business Overview
9.13.5 Pacific Shuanglin Recent Developments
9.14 Boya Bio-Pharmaceutical
9.14.1 Boya Bio-Pharmaceutical Plasma Derived Medicine Basic Information
9.14.2 Boya Bio-Pharmaceutical Plasma Derived Medicine Product Overview
9.14.3 Boya Bio-Pharmaceutical Plasma Derived Medicine Product Market Performance
9.14.4 Boya Bio-Pharmaceutical Business Overview
9.14.5 Boya Bio-Pharmaceutical Recent Developments
9.15 Paisi Feike Biology Pharmacy Co., Ltd.
9.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Basic Information
9.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Overview
9.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Market Performance
9.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
9.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
9.16 Xinjiang Deyuan Bioengineering
9.16.1 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Basic Information
9.16.2 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Overview
9.16.3 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Market Performance
9.16.4 Xinjiang Deyuan Bioengineering Business Overview
9.16.5 Xinjiang Deyuan Bioengineering Recent Developments
9.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
9.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Basic Information
9.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Overview
9.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Market Performance
9.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
9.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
9.18 Shenzhen Weiguang
9.18.1 Shenzhen Weiguang Plasma Derived Medicine Basic Information
9.18.2 Shenzhen Weiguang Plasma Derived Medicine Product Overview
9.18.3 Shenzhen Weiguang Plasma Derived Medicine Product Market Performance
9.18.4 Shenzhen Weiguang Business Overview
9.18.5 Shenzhen Weiguang Recent Developments
9.19 Shanxi Kangbao
9.19.1 Shanxi Kangbao Plasma Derived Medicine Basic Information
9.19.2 Shanxi Kangbao Plasma Derived Medicine Product Overview
9.19.3 Shanxi Kangbao Plasma Derived Medicine Product Market Performance
9.19.4 Shanxi Kangbao Business Overview
9.19.5 Shanxi Kangbao Recent Developments
9.20 Nanyue Biopharming Corporation Ltd
9.20.1 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Basic Information
9.20.2 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Overview
9.20.3 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Market Performance
9.20.4 Nanyue Biopharming Corporation Ltd Business Overview
9.20.5 Nanyue Biopharming Corporation Ltd Recent Developments
10 PLASMA DERIVED MEDICINE MARKET FORECAST BY REGION
10.1 Global Plasma Derived Medicine Market Size Forecast
10.2 Global Plasma Derived Medicine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Plasma Derived Medicine Market Size Forecast by Country
10.2.3 Asia Pacific Plasma Derived Medicine Market Size Forecast by Region
10.2.4 South America Plasma Derived Medicine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Plasma Derived Medicine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Plasma Derived Medicine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Plasma Derived Medicine by Type (2025-2030)
11.1.2 Global Plasma Derived Medicine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Plasma Derived Medicine by Type (2025-2030)
11.2 Global Plasma Derived Medicine Market Forecast by Application (2025-2030)
11.2.1 Global Plasma Derived Medicine Sales (Kilotons) Forecast by Application
11.2.2 Global Plasma Derived Medicine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Plasma Derived Medicine Market Size Comparison by Region (M USD)
Table 5. Global Plasma Derived Medicine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Plasma Derived Medicine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Plasma Derived Medicine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Plasma Derived Medicine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Medicine as of 2022)
Table 10. Global Market Plasma Derived Medicine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Plasma Derived Medicine Sales Sites and Area Served
Table 12. Manufacturers Plasma Derived Medicine Product Type
Table 13. Global Plasma Derived Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Plasma Derived Medicine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma Derived Medicine Market Challenges
Table 22. Global Plasma Derived Medicine Sales by Type (Kilotons)
Table 23. Global Plasma Derived Medicine Market Size by Type (M USD)
Table 24. Global Plasma Derived Medicine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Plasma Derived Medicine Sales Market Share by Type (2019-2024)
Table 26. Global Plasma Derived Medicine Market Size (M USD) by Type (2019-2024)
Table 27. Global Plasma Derived Medicine Market Size Share by Type (2019-2024)
Table 28. Global Plasma Derived Medicine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Plasma Derived Medicine Sales (Kilotons) by Application
Table 30. Global Plasma Derived Medicine Market Size by Application
Table 31. Global Plasma Derived Medicine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Table 33. Global Plasma Derived Medicine Sales by Application (2019-2024) & (M USD)
Table 34. Global Plasma Derived Medicine Market Share by Application (2019-2024)
Table 35. Global Plasma Derived Medicine Sales Growth Rate by Application (2019-2024)
Table 36. Global Plasma Derived Medicine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Plasma Derived Medicine Sales Market Share by Region (2019-2024)
Table 38. North America Plasma Derived Medicine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Plasma Derived Medicine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Plasma Derived Medicine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Plasma Derived Medicine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Plasma Derived Medicine Sales by Region (2019-2024) & (Kilotons)
Table 43. Takeda Plasma Derived Medicine Basic Information
Table 44. Takeda Plasma Derived Medicine Product Overview
Table 45. Takeda Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Takeda Business Overview
Table 47. Takeda Plasma Derived Medicine SWOT Analysis
Table 48. Takeda Recent Developments
Table 49. CSL Plasma Derived Medicine Basic Information
Table 50. CSL Plasma Derived Medicine Product Overview
Table 51. CSL Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CSL Business Overview
Table 53. CSL Plasma Derived Medicine SWOT Analysis
Table 54. CSL Recent Developments
Table 55. Grifols Plasma Derived Medicine Basic Information
Table 56. Grifols Plasma Derived Medicine Product Overview
Table 57. Grifols Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Grifols Plasma Derived Medicine SWOT Analysis
Table 59. Grifols Business Overview
Table 60. Grifols Recent Developments
Table 61. Octapharma Plasma Derived Medicine Basic Information
Table 62. Octapharma Plasma Derived Medicine Product Overview
Table 63. Octapharma Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Octapharma Business Overview
Table 65. Octapharma Recent Developments
Table 66. Kedrion Plasma Derived Medicine Basic Information
Table 67. Kedrion Plasma Derived Medicine Product Overview
Table 68. Kedrion Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Kedrion Business Overview
Table 70. Kedrion Recent Developments
Table 71. LFB Group Plasma Derived Medicine Basic Information
Table 72. LFB Group Plasma Derived Medicine Product Overview
Table 73. LFB Group Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. LFB Group Business Overview
Table 75. LFB Group Recent Developments
Table 76. Biotest Plasma Derived Medicine Basic Information
Table 77. Biotest Plasma Derived Medicine Product Overview
Table 78. Biotest Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Biotest Business Overview
Table 80. Biotest Recent Developments
Table 81. BPL Plasma Derived Medicine Basic Information
Table 82. BPL Plasma Derived Medicine Product Overview
Table 83. BPL Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. BPL Business Overview
Table 85. BPL Recent Developments
Table 86. Shanghai RAAS Plasma Derived Medicine Basic Information
Table 87. Shanghai RAAS Plasma Derived Medicine Product Overview
Table 88. Shanghai RAAS Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Shanghai RAAS Business Overview
Table 90. Shanghai RAAS Recent Developments
Table 91. China Biologic Products Plasma Derived Medicine Basic Information
Table 92. China Biologic Products Plasma Derived Medicine Product Overview
Table 93. China Biologic Products Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. China Biologic Products Business Overview
Table 95. China Biologic Products Recent Developments
Table 96. Hualan Biological Engineering Inc. Plasma Derived Medicine Basic Information
Table 97. Hualan Biological Engineering Inc. Plasma Derived Medicine Product Overview
Table 98. Hualan Biological Engineering Inc. Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hualan Biological Engineering Inc. Business Overview
Table 100. Hualan Biological Engineering Inc. Recent Developments
Table 101. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Basic Information
Table 102. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Overview
Table 103. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Beijing Tiantan Biological Products Corp Business Overview
Table 105. Beijing Tiantan Biological Products Corp Recent Developments
Table 106. Pacific Shuanglin Plasma Derived Medicine Basic Information
Table 107. Pacific Shuanglin Plasma Derived Medicine Product Overview
Table 108. Pacific Shuanglin Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Pacific Shuanglin Business Overview
Table 110. Pacific Shuanglin Recent Developments
Table 111. Boya Bio-Pharmaceutical Plasma Derived Medicine Basic Information
Table 112. Boya Bio-Pharmaceutical Plasma Derived Medicine Product Overview
Table 113. Boya Bio-Pharmaceutical Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Boya Bio-Pharmaceutical Business Overview
Table 115. Boya Bio-Pharmaceutical Recent Developments
Table 116. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Basic Information
Table 117. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Overview
Table 118. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
Table 120. Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
Table 121. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Basic Information
Table 122. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Overview
Table 123. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Xinjiang Deyuan Bioengineering Business Overview
Table 125. Xinjiang Deyuan Bioengineering Recent Developments
Table 126. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Basic Information
Table 127. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Overview
Table 128. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
Table 130. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
Table 131. Shenzhen Weiguang Plasma Derived Medicine Basic Information
Table 132. Shenzhen Weiguang Plasma Derived Medicine Product Overview
Table 133. Shenzhen Weiguang Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Shenzhen Weiguang Business Overview
Table 135. Shenzhen Weiguang Recent Developments
Table 136. Shanxi Kangbao Plasma Derived Medicine Basic Information
Table 137. Shanxi Kangbao Plasma Derived Medicine Product Overview
Table 138. Shanxi Kangbao Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Shanxi Kangbao Business Overview
Table 140. Shanxi Kangbao Recent Developments
Table 141. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Basic Information
Table 142. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Overview
Table 143. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Nanyue Biopharming Corporation Ltd Business Overview
Table 145. Nanyue Biopharming Corporation Ltd Recent Developments
Table 146. Global Plasma Derived Medicine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 147. Global Plasma Derived Medicine Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Plasma Derived Medicine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 149. North America Plasma Derived Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Plasma Derived Medicine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 151. Europe Plasma Derived Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Plasma Derived Medicine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 153. Asia Pacific Plasma Derived Medicine Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Plasma Derived Medicine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 155. South America Plasma Derived Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Plasma Derived Medicine Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Plasma Derived Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Plasma Derived Medicine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 159. Global Plasma Derived Medicine Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Plasma Derived Medicine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 161. Global Plasma Derived Medicine Sales (Kilotons) Forecast by Application (2025-2030)
Table 162. Global Plasma Derived Medicine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Plasma Derived Medicine Market Size Comparison by Region (M USD)
Table 5. Global Plasma Derived Medicine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Plasma Derived Medicine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Plasma Derived Medicine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Plasma Derived Medicine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Medicine as of 2022)
Table 10. Global Market Plasma Derived Medicine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Plasma Derived Medicine Sales Sites and Area Served
Table 12. Manufacturers Plasma Derived Medicine Product Type
Table 13. Global Plasma Derived Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Plasma Derived Medicine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma Derived Medicine Market Challenges
Table 22. Global Plasma Derived Medicine Sales by Type (Kilotons)
Table 23. Global Plasma Derived Medicine Market Size by Type (M USD)
Table 24. Global Plasma Derived Medicine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Plasma Derived Medicine Sales Market Share by Type (2019-2024)
Table 26. Global Plasma Derived Medicine Market Size (M USD) by Type (2019-2024)
Table 27. Global Plasma Derived Medicine Market Size Share by Type (2019-2024)
Table 28. Global Plasma Derived Medicine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Plasma Derived Medicine Sales (Kilotons) by Application
Table 30. Global Plasma Derived Medicine Market Size by Application
Table 31. Global Plasma Derived Medicine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Table 33. Global Plasma Derived Medicine Sales by Application (2019-2024) & (M USD)
Table 34. Global Plasma Derived Medicine Market Share by Application (2019-2024)
Table 35. Global Plasma Derived Medicine Sales Growth Rate by Application (2019-2024)
Table 36. Global Plasma Derived Medicine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Plasma Derived Medicine Sales Market Share by Region (2019-2024)
Table 38. North America Plasma Derived Medicine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Plasma Derived Medicine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Plasma Derived Medicine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Plasma Derived Medicine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Plasma Derived Medicine Sales by Region (2019-2024) & (Kilotons)
Table 43. Takeda Plasma Derived Medicine Basic Information
Table 44. Takeda Plasma Derived Medicine Product Overview
Table 45. Takeda Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Takeda Business Overview
Table 47. Takeda Plasma Derived Medicine SWOT Analysis
Table 48. Takeda Recent Developments
Table 49. CSL Plasma Derived Medicine Basic Information
Table 50. CSL Plasma Derived Medicine Product Overview
Table 51. CSL Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CSL Business Overview
Table 53. CSL Plasma Derived Medicine SWOT Analysis
Table 54. CSL Recent Developments
Table 55. Grifols Plasma Derived Medicine Basic Information
Table 56. Grifols Plasma Derived Medicine Product Overview
Table 57. Grifols Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Grifols Plasma Derived Medicine SWOT Analysis
Table 59. Grifols Business Overview
Table 60. Grifols Recent Developments
Table 61. Octapharma Plasma Derived Medicine Basic Information
Table 62. Octapharma Plasma Derived Medicine Product Overview
Table 63. Octapharma Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Octapharma Business Overview
Table 65. Octapharma Recent Developments
Table 66. Kedrion Plasma Derived Medicine Basic Information
Table 67. Kedrion Plasma Derived Medicine Product Overview
Table 68. Kedrion Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Kedrion Business Overview
Table 70. Kedrion Recent Developments
Table 71. LFB Group Plasma Derived Medicine Basic Information
Table 72. LFB Group Plasma Derived Medicine Product Overview
Table 73. LFB Group Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. LFB Group Business Overview
Table 75. LFB Group Recent Developments
Table 76. Biotest Plasma Derived Medicine Basic Information
Table 77. Biotest Plasma Derived Medicine Product Overview
Table 78. Biotest Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Biotest Business Overview
Table 80. Biotest Recent Developments
Table 81. BPL Plasma Derived Medicine Basic Information
Table 82. BPL Plasma Derived Medicine Product Overview
Table 83. BPL Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. BPL Business Overview
Table 85. BPL Recent Developments
Table 86. Shanghai RAAS Plasma Derived Medicine Basic Information
Table 87. Shanghai RAAS Plasma Derived Medicine Product Overview
Table 88. Shanghai RAAS Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Shanghai RAAS Business Overview
Table 90. Shanghai RAAS Recent Developments
Table 91. China Biologic Products Plasma Derived Medicine Basic Information
Table 92. China Biologic Products Plasma Derived Medicine Product Overview
Table 93. China Biologic Products Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. China Biologic Products Business Overview
Table 95. China Biologic Products Recent Developments
Table 96. Hualan Biological Engineering Inc. Plasma Derived Medicine Basic Information
Table 97. Hualan Biological Engineering Inc. Plasma Derived Medicine Product Overview
Table 98. Hualan Biological Engineering Inc. Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hualan Biological Engineering Inc. Business Overview
Table 100. Hualan Biological Engineering Inc. Recent Developments
Table 101. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Basic Information
Table 102. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Overview
Table 103. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Beijing Tiantan Biological Products Corp Business Overview
Table 105. Beijing Tiantan Biological Products Corp Recent Developments
Table 106. Pacific Shuanglin Plasma Derived Medicine Basic Information
Table 107. Pacific Shuanglin Plasma Derived Medicine Product Overview
Table 108. Pacific Shuanglin Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Pacific Shuanglin Business Overview
Table 110. Pacific Shuanglin Recent Developments
Table 111. Boya Bio-Pharmaceutical Plasma Derived Medicine Basic Information
Table 112. Boya Bio-Pharmaceutical Plasma Derived Medicine Product Overview
Table 113. Boya Bio-Pharmaceutical Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Boya Bio-Pharmaceutical Business Overview
Table 115. Boya Bio-Pharmaceutical Recent Developments
Table 116. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Basic Information
Table 117. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Overview
Table 118. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
Table 120. Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
Table 121. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Basic Information
Table 122. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Overview
Table 123. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Xinjiang Deyuan Bioengineering Business Overview
Table 125. Xinjiang Deyuan Bioengineering Recent Developments
Table 126. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Basic Information
Table 127. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Overview
Table 128. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
Table 130. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
Table 131. Shenzhen Weiguang Plasma Derived Medicine Basic Information
Table 132. Shenzhen Weiguang Plasma Derived Medicine Product Overview
Table 133. Shenzhen Weiguang Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Shenzhen Weiguang Business Overview
Table 135. Shenzhen Weiguang Recent Developments
Table 136. Shanxi Kangbao Plasma Derived Medicine Basic Information
Table 137. Shanxi Kangbao Plasma Derived Medicine Product Overview
Table 138. Shanxi Kangbao Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Shanxi Kangbao Business Overview
Table 140. Shanxi Kangbao Recent Developments
Table 141. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Basic Information
Table 142. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Overview
Table 143. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Nanyue Biopharming Corporation Ltd Business Overview
Table 145. Nanyue Biopharming Corporation Ltd Recent Developments
Table 146. Global Plasma Derived Medicine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 147. Global Plasma Derived Medicine Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Plasma Derived Medicine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 149. North America Plasma Derived Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Plasma Derived Medicine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 151. Europe Plasma Derived Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Plasma Derived Medicine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 153. Asia Pacific Plasma Derived Medicine Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Plasma Derived Medicine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 155. South America Plasma Derived Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Plasma Derived Medicine Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Plasma Derived Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Plasma Derived Medicine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 159. Global Plasma Derived Medicine Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Plasma Derived Medicine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 161. Global Plasma Derived Medicine Sales (Kilotons) Forecast by Application (2025-2030)
Table 162. Global Plasma Derived Medicine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Plasma Derived Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma Derived Medicine Market Size (M USD), 2019-2030
Figure 5. Global Plasma Derived Medicine Market Size (M USD) (2019-2030)
Figure 6. Global Plasma Derived Medicine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma Derived Medicine Market Size by Country (M USD)
Figure 11. Plasma Derived Medicine Sales Share by Manufacturers in 2023
Figure 12. Global Plasma Derived Medicine Revenue Share by Manufacturers in 2023
Figure 13. Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Plasma Derived Medicine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Plasma Derived Medicine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Plasma Derived Medicine Market Share by Type
Figure 18. Sales Market Share of Plasma Derived Medicine by Type (2019-2024)
Figure 19. Sales Market Share of Plasma Derived Medicine by Type in 2023
Figure 20. Market Size Share of Plasma Derived Medicine by Type (2019-2024)
Figure 21. Market Size Market Share of Plasma Derived Medicine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Plasma Derived Medicine Market Share by Application
Figure 24. Global Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Figure 25. Global Plasma Derived Medicine Sales Market Share by Application in 2023
Figure 26. Global Plasma Derived Medicine Market Share by Application (2019-2024)
Figure 27. Global Plasma Derived Medicine Market Share by Application in 2023
Figure 28. Global Plasma Derived Medicine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Plasma Derived Medicine Sales Market Share by Region (2019-2024)
Figure 30. North America Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Plasma Derived Medicine Sales Market Share by Country in 2023
Figure 32. U.S. Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Plasma Derived Medicine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Plasma Derived Medicine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Plasma Derived Medicine Sales Market Share by Country in 2023
Figure 37. Germany Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Plasma Derived Medicine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Plasma Derived Medicine Sales Market Share by Region in 2023
Figure 44. China Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Plasma Derived Medicine Sales and Growth Rate (Kilotons)
Figure 50. South America Plasma Derived Medicine Sales Market Share by Country in 2023
Figure 51. Brazil Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Plasma Derived Medicine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Plasma Derived Medicine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Plasma Derived Medicine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Plasma Derived Medicine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Plasma Derived Medicine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Plasma Derived Medicine Market Share Forecast by Type (2025-2030)
Figure 65. Global Plasma Derived Medicine Sales Forecast by Application (2025-2030)
Figure 66. Global Plasma Derived Medicine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Plasma Derived Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma Derived Medicine Market Size (M USD), 2019-2030
Figure 5. Global Plasma Derived Medicine Market Size (M USD) (2019-2030)
Figure 6. Global Plasma Derived Medicine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma Derived Medicine Market Size by Country (M USD)
Figure 11. Plasma Derived Medicine Sales Share by Manufacturers in 2023
Figure 12. Global Plasma Derived Medicine Revenue Share by Manufacturers in 2023
Figure 13. Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Plasma Derived Medicine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Plasma Derived Medicine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Plasma Derived Medicine Market Share by Type
Figure 18. Sales Market Share of Plasma Derived Medicine by Type (2019-2024)
Figure 19. Sales Market Share of Plasma Derived Medicine by Type in 2023
Figure 20. Market Size Share of Plasma Derived Medicine by Type (2019-2024)
Figure 21. Market Size Market Share of Plasma Derived Medicine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Plasma Derived Medicine Market Share by Application
Figure 24. Global Plasma Derived Medicine Sales Market Share by Application (2019-2024)
Figure 25. Global Plasma Derived Medicine Sales Market Share by Application in 2023
Figure 26. Global Plasma Derived Medicine Market Share by Application (2019-2024)
Figure 27. Global Plasma Derived Medicine Market Share by Application in 2023
Figure 28. Global Plasma Derived Medicine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Plasma Derived Medicine Sales Market Share by Region (2019-2024)
Figure 30. North America Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Plasma Derived Medicine Sales Market Share by Country in 2023
Figure 32. U.S. Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Plasma Derived Medicine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Plasma Derived Medicine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Plasma Derived Medicine Sales Market Share by Country in 2023
Figure 37. Germany Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Plasma Derived Medicine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Plasma Derived Medicine Sales Market Share by Region in 2023
Figure 44. China Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Plasma Derived Medicine Sales and Growth Rate (Kilotons)
Figure 50. South America Plasma Derived Medicine Sales Market Share by Country in 2023
Figure 51. Brazil Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Plasma Derived Medicine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Plasma Derived Medicine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Plasma Derived Medicine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Plasma Derived Medicine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Plasma Derived Medicine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Plasma Derived Medicine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Plasma Derived Medicine Market Share Forecast by Type (2025-2030)
Figure 65. Global Plasma Derived Medicine Sales Forecast by Application (2025-2030)
Figure 66. Global Plasma Derived Medicine Market Share Forecast by Application (2025-2030)
